Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Glipizide impurity 13 is a recognized impurity associated with Glipizide, an antidiabetic medication. This compound serves as a critical reference standard for the analysis and quality control of Glipizide formulations. Its identification and quantification are essential for ensuring the purity and safety of pharmaceutical products containing Glipizide, contributing to regulatory compliance in drug development and manufacturing. -
Drug Impurity
Estradiol impurity 7, also known as delta9,11-Estradiol, is a known impurity associated with Estradiol. This compound is primarily studied for its potential impacts on hormonal assays and the evaluation of pharmaceutical purity. Its presence may influence the biological activity of formulations containing Estradiol, making it relevant for quality control in drug development and analysis. -
Drug Impurity
Bupropion impurity 14 is a chemical impurity associated with Bupropion, a widely used antidepressant and smoking cessation aid. Characterized as a byproduct in the synthesis of Bupropion, this compound serves as an essential reference standard in pharmaceutical analysis and quality control. It is crucial for ensuring the safety and efficacy of Bupropion formulations in both research and clinical settings. -
Drug Impurity
Glycopyrrolate impurity 1 bromide is a known impurity of Glycopyrrolate bromide, primarily categorized as a drug impurity. It is utilized in chemical research to assess the purity and quality of Glycopyrrolate formulations. Its presence is crucial for regulatory compliance and in analytical studies aimed at understanding the pharmacological profile and safety of Glycopyrrolate-related compounds. -
Drug Impurity
Ranolazine impurity 9 is a byproduct of Ranolazine synthesis, serving as a chemical marker for purity assessment in pharmaceutical research. Its characterization is crucial for quality control in drug development, particularly in the evaluation of Ranolazine formulations. This impurity can aid in understanding the overall safety and efficacy profiles of the primary compound in clinical applications. -
Drug Impurity
4-Chloro Trazodone is a known drug impurity with a primary mechanism of action linked to serotonergic modulation. It is relevant in the study of the pharmacological profiles of trazodone and its metabolites. This compound is utilized in analytical chemistry and quality control processes to evaluate the presence and concentration of impurities in pharmaceutical formulations. -
Drug Impurity
Metoprolol impurity 2 hydrochloride is a secondary metabolite related to Metoprolol hydrochloride, functioning primarily as a drug impurity. Its presence is important for analytical research in pharmaceutical development, aiding in the evaluation of drug purity and stability. This compound serves as a reference material for quality control and regulatory compliance in drug manufacturing processes. -
Drug Impurity
Rivaroxaban impurity 24 is a known impurity associated with Rivaroxaban, an oral anticoagulant that inhibits Factor Xa, thereby blocking the conversion of prothrombin to thrombin. Understanding this impurity is essential for quality control and assurance in the production of Rivaroxaban. This compound serves as an important reference standard for the analysis of drug purity and stability, making it valuable for pharmaceutical research and development applications. -
Drug Impurity
Azithromycin impurity 2 is a known impurity associated with the antibiotic Azithromycin. It serves as an important reference standard for analytical and quality control applications in pharmaceutical research. The characterization and quantification of this impurity can aid in the assessment of drug purity and efficacy, contributing to the development of safer and more effective antibiotic formulations. -
Drug Impurity
Azilsartan impurity 24, also known as O-Desethyl azilsartan, is a drug impurity associated with Azilsartan. Its presence in formulations is important for quality control and regulatory compliance in pharmaceutical development. Researchers may utilize this compound to assess the purity of Azilsartan and to investigate its potential effects on biological activity. -
Drug Intermediate
(1-Benzylpiperidin-3-yl)methanol is a chemical intermediate primarily used in the synthesis of pharmaceutical compounds. This compound facilitates research into Alzheimer's disease by serving as a precursor for biologically active molecules. Its applications extend to the development of potential therapeutic agents aimed at understanding and treating neurodegenerative disorders. -
Drug Impurity
Celecoxib impurity 1 is a chemical impurity associated with the synthesis of Celecoxib. Its presence can impact the purity and efficacy of pharmaceutical formulations. This impurity serves as a critical reference standard for quality control and analytical processes in drug development, ensuring compliance with regulatory requirements and improving the safety profile of Celecoxib-containing products. -
Drug Impurity
Apixaban impurity 52 is a characterized impurity of the anticoagulant Apixaban. This compound serves as a critical reference standard for researchers assessing the purity and quality of Apixaban in pharmaceutical formulations. Its analysis is essential for ensuring compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Allopurinol impurity 3 is a chemical impurity associated with allopurinol, a medication primarily used for the management of gout and hyperuricemia. This impurity is relevant for analytical studies, quality control processes, and the regulatory assessment of allopurinol formulations. Understanding and characterizing such impurities is essential for ensuring the safety and efficacy of pharmaceutical products. -
Drug Impurity
Acyclovir impurity 2, also known as O-[(Guanin-7-yl)methyl] acyclovir, serves as a drug impurity associated with Acyclovir. This compound is relevant for quality control and analytical studies involving Acyclovir formulations. Its characterization is essential for ensuring the purity and compliance of pharmaceutical products during drug development and manufacturing processes. -
Drug Impurity
Methylprednisolone impurity 8 is identified as a chemical impurity associated with Methylprednisolone. This impurity may be relevant in pharmaceutical research and quality control, particularly in assessing the purity and stability of Methylprednisolone formulations. Its characterization can support the development of reliable methods for purity analysis and compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Pregnenolone impurity 1 is a chemical impurity associated with Pregnenolone. Its presence is significant for quality control in the synthesis of Pregnenolone-based compounds. This reagent is useful in research focused on the characterization and quantification of drug impurities, ensuring the integrity and safety of pharmacological products. -
Drug Impurity
Ranitidine impurity 1, also known as N-Methylnitroacetamide, is a chemical impurity associated with the drug Ranitidine. This compound is important for studies focused on drug quality and safety, as it provides insights into the stability and degradation products of pharmaceutical formulations. Its analysis aids in ensuring compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Imatinib impurity 12 is a known impurity associated with the tyrosine kinase inhibitor Imatinib. Its primary relevance lies in the quality control and characterization of Imatinib formulations. This compound is essential for assessing purity levels and understanding the metabolic pathways during drug development and pharmacokinetic studies. Additionally, it serves as a critical reference for analytical chemists in regulatory compliance and validation processes. -
Drug Impurity
Rivaroxaban impurity 16 is a known impurity of the anticoagulant Rivaroxaban, which functions as a selective inhibitor of Factor Xa. This compound is essential for analytical and quality control studies in the pharmaceutical industry, particularly for assessing the purity and safety of Rivaroxaban formulations. Its role in research allows for a better understanding of drug metabolism and the identification of potential impacts on efficacy and toxicity. -
Drug Impurity
Clarithromycin impurity 11, also known as N-Desmethyl Clarithromycin (9E)-Oxime, is a known impurity associated with the antibiotic Clarithromycin. This compound is essential for analytical and regulatory purposes, aiding in the assessment of drug purity and stability. It is particularly relevant for quality control in pharmaceutical research and development, contributing to the understanding of the compound's metabolic pathways and potential side effects. -
Drug Impurity
Ranitidine impurity 4 is a known impurity of the gastric acid secretion inhibitor Ranitidine. This compound is primarily utilized in pharmaceutical research to assess the purity of Ranitidine formulations and evaluate the stability profiles of related drug products. Its presence can impact the safety and efficacy of the final pharmaceutical formulations, making it essential for quality control and regulatory compliance in drug development. -
Drug Impurity
Ranitidine impurity 13 is identified as an impurity associated with the antihistamine Ranitidine. This compound is critical for quality control and analytical studies in pharmaceutical research, ensuring the integrity and safety of Ranitidine formulations. It serves as a reference standard for assessing the purity and composition of Ranitidine products in compliance with regulatory guidelines. -
Drug Impurity
Prasugrel impurity 7 is a chemical impurity associated with the synthesis of Prasugrel, an antiplatelet medication targeting the P2Y12 receptor. This impurity is critical for quality control and analytical research in pharmaceutical development, enabling the assessment of product purity and safety. Researchers can utilize this reagent to study the effects of impurities on drug efficacy and metabolism, thus contributing to the overall understanding of pharmacological profiles and compliance with regulatory standards. -
Drug Impurity
Levofloxacin impurity 14 is a recognized impurity of the fluoroquinolone antibiotic levofloxacin. As a drug impurity, it plays a critical role in the assessment of the purity and quality of levofloxacin in pharmaceutical formulations. Researchers utilize this compound to conduct stability studies and analytical methods, ensuring compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Telmisartan impurity 10 is a drug impurity associated with Telmisartan, an angiotensin II receptor blocker. This compound serves as a valuable reference standard for the assessment of Telmisartan quality and purity in pharmaceutical formulations. It is essential for analytical research and quality control applications to ensure compliance with regulatory standards. -
Drug Intermediate
N-Demethy EM-163 is a key intermediate in the synthesis of the compound EM-163. This reagent facilitates the production of EM-163, which is recognized for its potential therapeutic applications. Researchers utilize N-Demethy EM-163 in drug development processes, particularly in studying the pharmacological effects of EM-163 and its related derivatives. -
Drug Impurity
Azithromycin impurity 14, also known as N'-(Desmethyl)azithromycin, serves as an impurity associated with the antibiotic azithromycin. This compound is significant for analytical chemistry and quality control in pharmaceutical research, aiding in the assessment of drug purity and stability. Its characterization is essential for understanding the potential effects of impurities on drug efficacy and safety. -
Drug Intermediate
2,2,6-Trimethylcyclohexanone, a versatile drug intermediate, plays a crucial role in the synthesis of β-ionone, an important compound in fragrance and flavor industries. Its structural properties make it an essential building block for various synthetic routes in organic chemistry. Researchers utilize this compound in the development of bioactive molecules and in the study of related chemical transformations. -
Drug Impurity
Empagliflozin impurity 15 is an impurity of Empagliflozin, a selective inhibitor of sodium-glucose co-transporter 2 (SGLT2). This compound is utilized primarily for analytical research to assess the purity and stability of Empagliflozin formulations. Its characterization contributes to the understanding of impurities in drug development and ensures quality control in pharmaceutical applications. -
Drug Impurity
Quetiapine impurity 1 is a known impurity related to the antipsychotic medication Quetiapine. This compound serves as an important reference standard for analytical studies and quality control processes in pharmaceutical research. Understanding and identifying impurities like Quetiapine impurity 1 is crucial for ensuring drug safety, efficacy, and compliance with regulatory standards. -
Drug Impurity
Sildenafil impurity 14 is a known impurity of Sildenafil, primarily analyzed in pharmacokinetic and drug stability studies. Its identification and characterization are essential in ensuring the purity and quality of Sildenafil products. This impurity serves as a valuable reference standard for analytical methods such as HPLC and mass spectrometry, enhancing the understanding of impurities in pharmaceutical formulations. -
Drug Impurity
Lincomycin impurity 42 hydrochloride is a chemical structure related to Lincomycin hydrochloride, identified as a drug impurity. This compound is utilized in analytical research to assess the purity and quality of Lincomycin hydrochloride in pharmaceutical formulations. Its detection and quantification can provide essential insights into the manufacturing process and compliance with regulatory standards in the pharmaceutical industry. -
Drug Impurity
Ranolazine impurity 4, also known as Ranolazine impurity B, is a chemical byproduct associated with the synthesis of the antianginal agent ranolazine. This impurity can be utilized in analytical chemistry for the characterization of ranolazine and in the evaluation of purity during formulation development. Its study aids in understanding the safety and efficacy of ranolazine formulations in pharmaceutical research. -
Drug Impurity
Amlodipine Impurity 1 is a synthesized impurity associated with Amlodipine, a calcium channel blocker. It is utilized primarily in drug analysis and quality control to ensure the purity and safety of pharmaceutical formulations. This compound can serve as a reference standard in research and development, aiding in the identification and quantification of impurities in Amlodipine products. -
Drug Impurity
Tadalafil impurity 2 is a chemical impurity associated with Tadalafil, functioning as a byproduct in its synthesis. This compound is primarily utilized in quality control and analytical studies to ensure the purity of pharmaceutical preparations. Its presence may affect the efficacy and safety profile of Tadalafil-containing formulations, making it critical in drug development and regulatory assessments. -
Drug Impurity
Acyclovir impurity 4 is a chemical impurity associated with the antiviral agent Acyclovir. This compound is primarily used in the context of analytical chemistry for the assessment of drug purity and quality control in pharmaceutical formulations. Research applications include method development for identification and quantification of impurities in Acyclovir samples, contributing to the overall safety and efficacy evaluation of antiviral therapies. -
Drug Impurity
Atenolol impurity 9 is a chemical impurity related to the antihypertensive agent Atenolol. This compound is primarily utilized in pharmaceutical research to assess the purity and stability of Atenolol formulations. Its characterization is essential in ensuring compliance with regulatory standards for drug quality and safety. -
Drug Impurity
Febuxostat impurity 13 is a known impurity associated with the drug Febuxostat, which is a selective inhibitor of xanthine oxidase. This impurity is significant for quality control and method development in pharmaceutical research. Its analysis can aid in understanding the compound's stability, purity, and overall quality in formulations, contributing to the regulatory compliance of pharmaceutical products. -
Drug Impurity
N-Trityl candesartan cilexetil is identified as a drug impurity associated with the angiotensin II receptor antagonist class of compounds. Its presence may affect the pharmacological profile and efficacy of the primary drug. This reagent is valuable for analytical studies in drug development and quality control, particularly in evaluating the purity of candesartan cilexetil formulations. -
Drug Intermediate Control
Ethyl-2-(2-pyridyl)-4-(bromomethyl)-Thiazole-5-Carboxylate serves as a valuable synthetic intermediate in pharmaceutical synthesis. This compound exhibits potential utility in the development of novel therapeutic agents, enabling the creation of complex thiazole derivatives. Its application is essential in drug discovery processes focused on various biological targets, allowing researchers to explore new pathways in medicinal chemistry. -
Drug Intermediate
tert-Butyl 4-(1H-indol-4-yl)piperazine-1-carboxylate functions as a synthetic intermediate in pharmaceutical synthesis. This compound is valuable for the development of various bioactive molecules due to its piperazine and indole functionalities, contributing to the modulation of diverse biological targets. Its application is essential in drug discovery and development processes. -
Drug Impurity
Prednisolone Impurity 1 is a known impurity associated with the corticosteroid prednisolone. It serves as an important reference standard for analytical methods and quality control processes in pharmaceutical research. Its characterization and quantification are crucial for ensuring the purity and efficacy of prednisolone formulations. This reagent is widely utilized in stability studies and method development for drug formulation analysis. -
Drug Impurity
Mirabegron impurity 11 is a specific impurity associated with the pharmaceutical agent Mirabegron, a β3-adrenergic agonist. This compound may serve as a valuable reference standard in the quality control and analytical assessment of Mirabegron formulations. Researchers can utilize this impurity for studies related to pharmacokinetics, stability testing, and regulatory compliance in drug development. -
Drug Impurity
Rivaroxaban impurity 14 is an identified impurity of the anticoagulant Rivaroxaban, primarily targeting factor Xa. This impurity can be utilized in analytical and quality control studies to assess the purity of Rivaroxaban formulations. Its presence is important for regulatory compliance and to ensure the safety and efficacy of drug products in development and production. -
Drug Impurity
Moxifloxacin impurity 3 (6,8-Dimethoxymoxifloxacin) is identified as a drug impurity of Moxifloxacin. This compound is relevant for analytical chemistry and pharmaceutical development, specifically for quality control and stability testing of Moxifloxacin formulations. Its characterization can provide insights into the stability and degradation pathways of the primary drug substance. -
Drug Impurity
Dabigatran impurity 80 is a chemical impurity associated with the anticoagulant drug Dabigatran. This reagent serves as a critical reference standard for analytical studies, quality control assessments, and impurity profiling in pharmaceutical research. Its presence in drug formulations can impact efficacy and patient safety, making it essential for stability testing and regulatory compliance in the development of Dabigatran-containing products. -
Drug Impurity
Febuxostat impurity 9, also known as Desisobutyl febuxostat, is a chemical impurity associated with the drug Febuxostat. It is primarily relevant in the context of pharmaceutical research and development, particularly in the evaluation of drug purity and safety. This impurity can be employed in studies assessing the metabolism and pharmacokinetics of Febuxostat, aiding in the understanding of potential effects and interactions within biological systems. -
Gentamicin sulfate Impurity
2-Deoxystreptamine dihydrobromide serves as an impurity of Gentamicin sulfate, a broad-spectrum aminoglycoside antibiotic. This compound is of significant interest in the quality control and analysis of Gentamicin formulations, enabling researchers to assess purity and identify potential contaminants. Its study is crucial for understanding the pharmacological profile and safety assessment of aminoglycosides in therapeutic applications. -
Drug Intermediate
3-Methoxy-4-(methoxymethoxy)aniline serves as a key pharmaceutical intermediate with applications in the synthesis of histone deacetylase (HDAC) inhibitors. This compound's structure facilitates the development of various bioactive molecules, enabling the exploration of therapeutic strategies in cancer and other diseases associated with epigenetic regulation. Its role in drug discovery makes it an important reagent for researchers focused on epigenetic therapies.
